ARTICLE | Company News
Cerep, sanofi-aventis deal
December 15, 2008 8:00 AM UTC
The partners signed a license agreement giving sanofi-aventis rights to a neuropeptide Y receptor Y1 (NPY1R) antagonist that the companies co-discovered under a 1998 deal. The compound is in preclini...